PDGFRA CAR mRNA-LNP

Name: PDGFRA CAR mRNA-LNP
SKU: TDLD-0825-LD38
Rating: 5 (1 reviews)

Datasheet

Cat. No.: TDLD-0825-LD38

PDGFRA CAR mRNA-LNP

PDGFRA CAR mRNA-LNP is a state-of-the-art messenger RNA (mRNA) lipid nanoparticle (LNP) system, specifically engineered for efficient in vitro and in vivo protein expression. This LNP encapsulates mRNA encoding the Chimeric Antigen Receptor (CAR) targeting Platelet-Derived Growth Factor Receptor Alpha (PDGFRA), serving as an excellent tool for investigating CAR-T cell therapy against PDGFRA-expressing tumors and studying receptor-specific immune modulation. Engineered with a proprietary lipid formulation for optimal mRNA encapsulation and delivery, it ensures high translation efficiency. Our LNP ensures uniform particle size, high encapsulation efficiency, stability, and effective delivery. Applications of PDGFRA CAR mRNA-LNP include monitoring CAR expression on transduced T cells and evaluating CAR-T cell functionality against PDGFRA-positive targets. Please note that this product is intended for research purposes only.

SPECIFIC INQUIRY

Payload:

Modification:

Lipid Formulation:

Dye:

Concentration:

Quantity:

Inquiry

For Research Use Only. Not for Diagnostic or Treatment Applications.

Payload Type	CAR mRNA
Payload	PDGFRA CAR mRNA
Modification	Unmodified

Module Type

Unconjugation

Lipid Formulation	SM102
Dye	Unlabeled
Application	Control; Gene Therapy; CAR-T
Format	Liquid
Concentration	0.1 mg/mL; 0.2 mg/mL; Other (Please Specify)

Size	65-120 nm
PDI	< 0.2
Zeta	± 20.0 mV
Encapsulate Efficiency	>90%

Storage

Store at 2-8°C